ClinicalTrials.Veeva

Menu

Effect of RING on Gastroesophageal Reflux (GERD) After RYGBP

C

Clinica Gastrobese

Status

Terminated

Conditions

Vomiting
Gastroesophageal Reflux Disease
Morbid Obesity

Treatments

Procedure: Sham Comparator: no ring
Procedure: RYGBP-RING

Study type

Interventional

Funder types

Other

Identifiers

NCT01212835
GASTROBESE 005

Details and patient eligibility

About

Silastic rings have been used around the gastric pouch in order to promote better weight loss after Roux-and-Y gastric bypass surgery ( RYGBP). However the investigators have shown that some patients developed gastroesophageal reflux disease after RYGBP in a previous study. The investigators hypothesized that the use of a silastic ring may play a role in promoting GERD after this operation.

Full description

This is a randomized controlled double blind trial designed to identify if the use of the ring induces food intolerance and vomiting which may lead a esophageal mucosal erosions and/or GERD symptoms.

Enrollment

114 estimated patients

Sex

All

Ages

18 to 58 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Indications for bariatric surgery (BMI over 40Kg/m2 or over 35Kg/m2 associated to a life-treating morbid conditions.
  • Acceptance to be submitted to a 24h pH-monitoring and esophageal manometry
  • No contra-indication for gastric bypass
  • Absence of previous gastric surgery
  • Option for open gastric bypass

Exclusion criteria

  • Inferior and superior total teeth prosthesis
  • Poor surgical conditions

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

114 participants in 2 patient groups

no ring
Sham Comparator group
Description:
Patients at this group will have RING REMOVED AT THE END OF SURGERY.
Treatment:
Procedure: Sham Comparator: no ring
RYGBP-Ring
Active Comparator group
Description:
Open Roux-en-Y gastric bypass with a silastic ring which is performed with linear cut stapler 100 mm and a biliopancreatic limb of 60 cm long and a alimentary limb of 100 cm long. All patients will have a 6.5 cm silastic ring located at the middle of the pouch above of the gastroenteroanastomosis.
Treatment:
Procedure: RYGBP-RING

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems